Michael D. Feldman

Papers

Total Citations

237

H-Index

About

Michael D. Feldman is a leading figure in head and neck surgical oncology, with a primary focus on the intersection of human papillomavirus (HPV)-related oropharyngeal cancer and minimally invasive surgical techniques. His most influential work, a 2010 study on transoral robotic surgery (TORS) and HPV status, has garnered over 230 citations, fundamentally shaping how clinicians approach oncologic outcomes in this patient population. By demonstrating that HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) patients have distinct, often more favorable, outcomes after TORS with adjuvant therapy, Feldman helped establish a paradigm shift toward de-escalation of treatment and robotic-assisted surgery as a standard of care. More recently, he has contributed to cutting-edge virome research, co-authoring a 2020 study that explores the viral landscape of HPV-positive tonsil cancer and neck metastases, opening new avenues for understanding tumor biology and potential therapeutic targets. His work bridges surgical innovation with molecular insights, making him a key voice in personalized, transoral approaches to head and neck cancer. Feldman’s research continues to influence both clinical practice and translational studies, solidifying his reputation as a pioneer in robotic surgery and HPV-driven disease management.